20 employees
Nutraceutical biotechnology company focused on alternative plant-based cannabinoids and psilocybin medical research
2018
$450K
from 1 investors over 1 rounds
M2Bio Sciences, Inc. raised $450K on December 30, 2020
Investors: ThreeD Capital Inc.